Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis

BACKGROUND: The need for more robust outcomes in multiple sclerosis (MS) clinical trials has been a main priority of the field for decades. Dissatisfaction with existing measures has led to several consensus meetings and initiatives over the past few decades in hopes of defining and gaining acceptan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mult Scler
Autores principales: Strober, Lauren, DeLuca, John, Benedict, Ralph HB, Jacobs, Adam, Cohen, Jeffrey A, Chiaravalloti, Nancy, Hudson, Lynn D, Rudick, Richard A, LaRocca, Nicholas G
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2018
Materias:
Original Research Papers
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6826875/
https://ncbi.nlm.nih.gov/pubmed/30334474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458518808204
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares